NCT07489794 URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS
| NCT ID | NCT07489794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 47 participants |
| Start Date | 2026-03-09 |
| Primary Completion | 2026-09-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 47 participants in total. It began in 2026-03-09 with a primary completion date of 2026-09-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the relationship between urinary incontinence severity and surface electromyography (EMG) findings in women with multiple sclerosis. It will also examine the association of urinary incontinence with disability, quality of life, physical activity, and fatigue.
Eligibility Criteria
Inclusion Criteria: Diagnosis of multiple sclerosis (MS) according to the 2017 revised McDonald criteria. Female patients aged 30-50 years (age range with higher prevalence of urinary incontinence in MS). Experiencing urinary incontinence (UI) symptoms according to the International Continence Society (ICS) definition. EDSS (Expanded Disability Status Scale) score below 6.5. Patients with no communication difficulties. - Exclusion Criteria: MS patients who do not provide consent to participate in the study. MS patients who have had a medication change within the last 6 months. Pregnant MS patients. History of vaginal or cesarean delivery within the last 6 months. Pelvic organ prolapse. Urinary tract infection \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07489794 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 50 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07489794 currently recruiting?
Yes, NCT07489794 is actively recruiting participants. Contact the research team at bsrr.aydinn@gmail.com for enrollment information.
Where is the NCT07489794 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07489794 clinical trial?
NCT07489794 is sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization. The trial plans to enroll 47 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.